Wall Street Insights

Here are some key updates from Wall Street as of Monday:

Morgan Stanley remains bullish on Nvidia and Broadcom, reiterating its overweight stance. The firm noted that this memory cycle is quite unique, with the data center’s strength being the key factor. They mentioned there are mixed signals in the market that could be misleading. While memory resources are top-notch in their coverage, they believe NVDA and AVGO are catching up fast.

Goldman Sachs has initiated coverage on Versigent, giving it a Buy rating with a target price of $48, suggesting a 20% upside. They see significant potential in the electrification sector.

BMO has downgraded Charles Schwab from Market Perform to Neutral, citing valuation concerns. Despite strong fundamentals, they believe the stock’s risk-return balance is now more favorable after a recent rally of about 20%.

BMO also initiated coverage on Crane with an Outperform rating, targeting $253, which indicates a potential upside of 17% due to the company’s exposure in Aerospace and Defense.

Cantor Fitzgerald has reiterated an overweight position on Tesla, emphasizing confidence ahead of their upcoming earnings report. They highlighted Tesla’s robotaxi division as a high-margin opportunity and expect the company to scale rapidly and capture substantial market share after commercialization.

Barclays upgraded Lumentum from equal weight to overweight, noting that the demand for transceivers and lasers remains strong. Their price target is unchanged at $1,000.

Goldman Sachs upgraded Urban Outfitters to a Buy rating with a target of $93, anticipating improved earnings. They also have upgraded Yeti to neutral, mentioning better growth prospects after positive channel checks.

Mizuho initiated coverage of BP with an Outperform rating, suggesting there’s room for growth in the oil and gas sector. They also started coverage on TotalEnergies with a similar rating and a target price of $103, pointing out their differentiated services.

CLSA initiated coverage of Microsoft and Adobe, praising Microsoft’s broad market presence despite some software issues. They have expressed confidence in Adobe as well, stating that its fundamentals are performing better than expected.

JP Morgan started coverage on Moog with an overweight rating, setting a price target of $520 for December 2027, hinting at a roughly 35% upside.

Rothschild & Co. began coverage of DPC Holdings, making a case for the metal components company’s robust market positioning amidst high barriers to entry.

Deutsche Bank initiated coverage of Regal Rexnord, assigning a Buy rating with a $286 price target, suggesting over 30% upside potential. Conversely, they’ve downgraded Monster from buy to hold due to valuation concerns as the stock’s recent performance makes it more reliant on exceeding optimistic expectations.

Citizens expressed optimism for Gloo Holdings, initiating coverage with an outperform rating and a target of $8.

HSBC has begun coverage of Apollo Global with a Buy rating, stating the company is well-positioned for future success. Morgan Stanley also upgraded Global Payments from equal weight to overweight, believing the stock is set for a rerating. They mentioned improvements in competitiveness for Genius and Worldpay, which could support sustainable growth.

Bank of America maintained its Buy rating on Apple as investors await earnings results later this month. They mentioned that component cost inflation could be a focus for analysts moving forward.

Jefferies upgraded Farbo Energy to Buy following a notable pullback in stock prices, seeing an improved risk-reward scenario.

Loup upgraded Harley-Davidson to Buy, citing increased confidence from dealer checks and raising their price target to $420, indicating about 30% upside potential.

Finally, BTIG initiated coverage on Brainsway as a Buy, citing several positive catalysts, while Wolf rated Mobility Global as Outperform, setting a price target of EUR 26.

Freedom Capital Markets upgraded Nevius from Hold to Buy, suggesting it may present a compelling entry point, while Leerink opened coverage on Shattuck Labs as an outperformer, noting their focus on differentiated products targeting Crohn’s disease.

Cantor Fitzgerald also expressed optimism for cannabis companies, starting coverage of Trulieve with an Overweight rating and a $15 price target. Citi began coverage on AerCap Holdings, noting the aerospace company’s growth potential in a booming sector.